Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 25 min ago
Peer-reviewedCC BY-NC-NDHepatology communications

Lower circulating angiotensinogen levels across ACLD stages are associated with hepatic dysfunction and mortality

  • Marlene Hintersteininger1
  • Benedikt Silvester Hofer1
  • Clemens Renhardt1
  • Benedikt Simbrunner1
  • Oliver Domenig2
  • Lorenz Balcar1
  • Mathias Jachs1
  • Georg Kramer1
  • Christian Sebesta1
  • Paul Thöne1
  • Paula Höfinger1
  • Michael Trauner1
3 more authors
  • Mattias Mandorfer1
  • Thomas Reiberger1
  • Lukas Hartl1
  1. 1Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
  2. 2Attoquant Diagnostics, Vienna, Austria
Read full textPDFCite

Related

  1. Very low-calorie diet reduces hepatic steatosis and remodels circulating metabolite-microRNAs networks in metabolic dysfunction-associated steatotic liver disease: A pilot study
    P. Deb, D. Bagar, P. Kumar +10
    medRxivPreprintAll rights reservedFull textEndocrinology & metabolismmedRxiv
  2. Comparison of Metabolic Dysfunction‐Associated Steatotic Liver Disease Between Individuals With Werner Syndrome and Those With Insulin‐Resistant Type 2 Diabetes: Hepatic Steatosis and Fibrosis Indices
    Makoto Miyabayashi, Masaya Koshizaka, Mayumi Shoji +29
    Geriatrics & gerontology internationalPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Successive and Isoform-Specific Remodeling of Hepatic Drug-Metabolizing Enzymes during Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis Progression
    Yusuke Ando, Takumi Arai, Yuki Tsukui +4
    Biological and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textPharmacology & toxicologyJ-STAGE
  4. N-Acetylgalactosamine-Conjugated Small Interfering RNA Targeting Hepatic Angiotensinogen in Hypertension: A Phase I Clinical Trial With Randomized Part A and Open-Label Part B.
    Jianxiong Zhang, Jingxuan Wu, Que Liu +11
    JAMA cardiologyPeer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMC
  5. From Sedation to Injury: Isoflurane‐Associated Hepatic Dysfunction: A Series of 3 Intriguing Cases
    Mohammad Nabeel Aamir Syed, Faina Qaiser, Fabeha Hilal Makhdoomi +3
    Clinical case reportsPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCPMCEurope PMC

Cite

BibTeXRIS
BibTeX
@article{hintersteininger2026lower,
  title = {{Lower circulating angiotensinogen levels across ACLD stages are associated with hepatic dysfunction and mortality}},
  author = {Marlene Hintersteininger and Benedikt Silvester Hofer and Clemens Renhardt and Benedikt Simbrunner and Oliver Domenig and Lorenz Balcar and Mathias Jachs and Georg Kramer and Christian Sebesta and Paul Thöne and Paula Höfinger and Michael Trauner and Mattias Mandorfer and Thomas Reiberger and Lukas Hartl},
  journal = {Hepatology communications},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13668287},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Lower circulating angiotensinogen levels across ACLD stages are associated with hepatic dysfunction and mortality
AU  - Marlene Hintersteininger
AU  - Benedikt Silvester Hofer
AU  - Clemens Renhardt
AU  - Benedikt Simbrunner
AU  - Oliver Domenig
AU  - Lorenz Balcar
AU  - Mathias Jachs
AU  - Georg Kramer
AU  - Christian Sebesta
AU  - Paul Thöne
AU  - Paula Höfinger
AU  - Michael Trauner
AU  - Mattias Mandorfer
AU  - Thomas Reiberger
AU  - Lukas Hartl
PY  - 2026
DA  - 2026/10/14
JO  - Hepatology communications
UR  - https://europepmc.org/article/PMC/PMC13668287
SN  - 2471-254X
ER  -